# Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative

> **NCT05286086** · NA · UNKNOWN · sponsor: **Corporacion Parc Tauli** · enrollment: 50 (estimated)

## Conditions studied

- Rectal Cancer, Adenocarcinoma
- Chemoradiotherapy

## Interventions

- **BEHAVIORAL:** prehabilitation

## Key facts

- **NCT ID:** NCT05286086
- **Lead sponsor:** Corporacion Parc Tauli
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03
- **Primary completion:** 2022-03
- **Final completion:** 2025-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05286086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05286086, "Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05286086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*